The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Granulosa Cell Tumor of the Ovary
Abstract
Adult granulosa cell tumor (GCT) of the ovary is oftentimes a hormonally active, stromal cell neoplasm that is distinguished by its ability to secrete sex steroids such as estrogen. Patients may present with vaginal bleeding caused by endometrial hyperplasia or uterine cancer as a result of prolonged exposure to tumor-derived estrogen. In addition, GCT is a vascular tumor that may occasionally rupture and result in abdominal pain, hemoperitoneum, and hypotension, mimicking an ectopic pregnancy in younger patients. GCT is usually associated with a mass on pelvic examination that is subsequently confirmed on ultrasonography. Surgery is required for definitive tissue diagnosis, staging, and tumor debulking. In older women, a total abdominal hysterectomy and bilateral salpingooophorectomy are typically performed. In women of childbearing age, a more conservative unilateral salpingo-oophorectomy may be performed, assuming that careful staging reveals that the disease has not extended outside of the involved ovary and that a concomitant uterine cancer has been excluded. Survival of patients with GCT is generally excellent because most patients present with early-stage disease, although certain high-risk patient groups may be identified. Stage is the most important prognostic factor, with a higher risk of relapse being associated with stages II through IV disease. In addition, patients with stage I disease associated with features such as large tumor size, high mitotic index, or tumor rupture may also be at higher risk in some series. The value of postoperative adjuvant therapy for high-risk patients has not been investigated by prospective randomized trials, which are difficult to perform because of the rarity of this tumor. Nonetheless, the use of adjuvant chemotherapy or radiation has sometimes been associated with prolonged disease-free survival in patients with high-risk features. Because of the propensity of GCT to recur years after initial diagnosis, prolonged surveillance with serial physical examination and serum tumor markers such as estradiol and inhibin is reasonable.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cannistra, S. A. (2004) · New England Journal of Medicine · doi:10.1056/nejmra041842 · Cited by 2,129
Self-citationWilliams, S. D., Birch, R., Einhorn, L. H., Irwin, L., Greco, F. A., & Loehrer, P. J. (1987) · New England Journal of Medicine · doi:10.1056/nejm198706043162302 · Cited by 1,170
Ovarian Tumors in a Cohort of Infertile Women
Rossing, M. A., Daling, J. R., Weiss, N. S., Moore, D. E., & Self, S. G. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409223311204 · Cited by 721
The Reduction in Risk of Ovarian Cancer Associated with Oral-Contraceptive Use
The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development* (1987) · New England Journal of Medicine · doi:10.1056/nejm198703123161102 · Cited by 365
Inhibin as a Marker for Granulosa-Cell Tumors
Lappöhn, R. E., Burger, H. G., Bouma, J., Bangah, M., Krans, M., & De Bruijn, H. W. A. (1989) · New England Journal of Medicine · doi:10.1056/nejm198909213211204 · Cited by 323
Cannistra, S. A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311183292108 · Cited by 291
Self-citationElevated Serum Inhibin Concentrations in Postmenopausal Women with Ovarian Tumors
Healy, D. L., Burger, H. G., Mamers, P., Jobling, T., Bangah, M., Quinn, M., Grant, P., Day, A. J., Rome, R., & Campbell, J. J. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311183292104 · Cited by 221
Colombo, N., Sessa, C., Landoni, F., Sartori, E., Pecorelli, S., & Mangioni, C. (1986) · Obstetrics and Gynecology · doi:10.1097/00006250-198602000-00020 · Cited by 140
Ovarian stimulation and granulosa-cell tumour
Willemsen, W. N. P., Kruitwagen, R. F. P. M., Bastiaans, L. A., Rolland, R., & Hanselaar, A. G. J. M. (1993) · The Lancet · doi:10.1016/0140-6736(93)91071-s · Cited by 137
Granulosa cell tumors in Israel: A study of 172 cases
Ohel, G., Kaneti, H., & Schenker, J. G. (1983) · Gynecologic Oncology · doi:10.1016/0090-8258(83)90083-5 · Cited by 132
Granulosa cell tumours of the ovary: Demographics, survival and the management of advanced disease
Savage, P. M., CONSTENLA, D., Fisher, C., Shepherd, J. H., Barton, D. P. J., Blake, P., & Gore, M. E. (1998) · Clinical Oncology · doi:10.1016/s0936-6555(98)80008-3 · Cited by 111
Characteristic Pattern of Genetic Aberrations in Ovarian Granulosa Cell Tumors
Mayr, D. C., Kaltz-Wittmer, C., Arbogast, S., et al. (2002) · Modern Pathology · doi:10.1097/01.mp.0000024290.55261.14 · Cited by 79
Inhibin forms in serum from postmenopausal women with ovarian cancers
Robertson, D. M., Cahir, N. F., Burger, H., Mamers, P. M., & Groome, N. P. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00656.x · Cited by 76
Evaluation of serum alkaline phosphatase determination in patients with positive bone scans
Cowan, R. J., & Young, K. A. (1973) · Cancer · doi:10.1002/1097-0142(197310)32:4<735::aid-cncr2820320401>3.0.co;2-k · Cited by 18
Cited by
Cannistra, S. A. (2004) · New England Journal of Medicine · doi:10.1056/nejmra041842 · Cited by 2,129
Self-citationMutation of FOXL2 in Granulosa-Cell Tumors of the Ovary
Shah, S. P., Köbel, M., Senz, J., Morin, R. D., Clarke, B. A., Wiegand, K. C., Leung, G., Zayed, A., Mehl, E., Kalloger, S. E., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902542 · Cited by 768
Hennessy, B. T., Coleman, R. L., & Markman, M. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61338-6 · Cited by 640
Cancer of the ovary, fallopian tube, and peritoneum: 2021 update
Berek, J. S., Renz, M., Kehoe, S., Kumar, L., & Friedlander, M. (2021) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.13878 · Cited by 514
Salani, R., Backes, F. J., Fung Kee Fung, M., Holschneider, C. H., Parker, L. P., Bristow, R. E., & Goff, B. A. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2011.03.008 · Cited by 428
Metadata
- Authors
- Schumer, S. T., & Cannistra, S. A.
- Venue
- Journal of Clinical Oncology
- Published
- 2003-03-15
- Volume
- 21
- Issue
- 6
- Pages
- 1180-1189
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2138493972
- Cited by
- 674
- References
- 14
- FWCI
- 16.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.